Akebia Therapeutics, Inc. (AKBA)
1.37
+0.03
(+2.24%)
USD |
NASDAQ |
Jan 21, 16:00
1.365
0.00 (0.00%)
Pre-Market: 20:00
Akebia Therapeutics Market Cap: 363.55M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 185.02B |
| Pfizer Inc. | 147.20B |
| Theravance Biopharma, Inc. | 1.032B |
| Zevra Therapeutics, Inc. | 508.37M |
| Organon & Co. | 2.493B |
Market Cap Related Metrics
| PS Ratio | 1.530 |
| Price to Book Value | 8.741 |
| Price to Free Cash Flow | 10.71 |
| Price | 1.37 |
| Earnings Yield | -5.55% |
| Operating PE Ratio | 19.41 |